Audentes Therapeutics Reports Fourth Quarter 2018 and Full Year Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. QCOM
6. ACN
7. AZN
8. ROIV
9. AAPL
10. HOOD

Go back to Audentes Therapeutics Reports Fourth Quarter 2018 and Full Year Financial Results and Provides Corporate Update

Audentes Therapeutics (BOLD) Tops Q4 EPS by 8c

February 27, 2019 4:22 PM EST

Audentes Therapeutics (NASDAQ: BOLD) reported Q4 EPS of ($0.84), $0.08 better than the analyst estimate of ($0.92).

For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.

... More